Platelets in vascular disease

Clinical Hemorheology and Microcirculation

Volumn 53, Issue 1-2, 2013, Pages 71-79

  Reinhart, W H ^a  

^a KANTONSSPITAL GRAUBÜNDEN   (Switzerland)

Author keywords

Aggregation; atherosclerosis; erythrocytes; inflammation; platelets

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CANGRELOR; CLOPIDOGREL; ELINOGREL; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; PRASUGREL; THROMBIN RECEPTOR ANTAGONIST; THROMBOXANE; THROMBOXANE A2; TICAGRELOR; TIROFIBAN; UNCLASSIFIED DRUG; VORAXAPAR;

ACUTE CORONARY SYNDROME; ARTERY THROMBOSIS; ARTICLE; ATHEROSCLEROSIS; BLEEDING; BLOOD RHEOLOGY; BLOOD VESSEL OCCLUSION; CELL ACTIVATION; CELL AGGREGATION; CEREBROVASCULAR ACCIDENT; DRUG MECHANISM; HEART INFARCTION; HEMOSTASIS; OPTIMAL DRUG DOSE; PATHOGENESIS; THROMBOCYTE; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE FUNCTION ANALYZER; THROMBOSIS; VASCULAR DISEASE;

ASPIRIN; ATHEROSCLEROSIS; BLOOD PLATELETS; HEMOSTASIS; HUMANS; PLAQUE, ATHEROSCLEROTIC; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; THROMBOSIS; TICLOPIDINE; VASCULAR DISEASES;

EID: 84872924548     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-2012-1577     Document Type: Article

References (60)

1. N. Alexandru, D. Popov and A. Georgescu, Platelet dysfunction in vascular pathologies and how can it be treated, Thrombosis Research 129 (2012), 116-126.
2. C. Anoniades, C. Bakogiannis, D. Tousoulis, M. Demosthenous, K. Marinou and C. Stefanadis, Platelet activation in atherogenesis associated with low-grade inflammation, Inflamm Allergy Drug Targets 9 (2010), 334-345.
3. Anonymous, Ethical guidelines for publication in clinical hemorheology and microcirculation, Clin Hemorheol Microcirc 44 (2010), 1-2.
4. Antithrombin Trialists' Collaboration, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ 324 (2002), 71-86.
5. R. Berent and H. Sinzinger, "Aspirin-resistance"? A few critical considerations on definition, terminology, diagnosis, clinical value, natural course of atherosclerotic disease, and therapeutic consequences, Vasa 40 (2011), 429-438.
6. G.R. Born, Aggregation of blood platelets by adenosine diphosphate and its reversal, Nature 194 (1962), 927-929.
7. X. Bosch, J. Marragat and J. Sanchis, Platelet glycoprotein Ib/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes, Cochrane Database Syst Rev 8 (2010), CD002130.
8. A.P. Burke, F.D. Kolodgie, A. Farb, D.K. Weber, G.T. Malcom, J. Smialek and R. Virmani, Healed plaque ruptures and sudden coronary death: Evidence that subclinical rupture has a role in plaque progression, Circulation 103(7) (2001), 934-940.
9. J. Caen and Q.Wu, Hageman factor, platelets and polyphosphates: Early history and recent connection, J Thromb Haemost 8 (2010), 1670-1674.
10. S.R. Coughlin, How the protease thrombin talks to cells, Proc Natl Acad Sci USA 96 (1999), 11023-11027.
11. M.M. Denis, N.D. Tolley, M. Bunting, H. Schwertz, H. Jiang, S. Lindemann, C.C. Yost, F.J. Rubner, K.H. Albertine, K.J. Swoboda, C.M. Fratto, E. Tolley, L.W. Kraiss, T.M. McIntyre, G.A. Zimmerman and A.S. Weyrich, Escaping the nuclear confines: Signal-dependent pre-mRNA splicing in anucleate platelets, Cell 122 (2005), 379-391.
12. V. Deplano and M. Siouffi, Experimental and numerical study of pulsatile flows through stenosis:Wall shear stress analysis, J Biomech 32 (1999), 1081-1090.
13. M. Eugster and W.H. Reinhart, The influence of the haematocrit on primary haemostasis in vitro, Thromb Haemost 94 (2005), 1213-1218.
14. E. Falk, Morphological features of unstable atherothrombotic plaques underlying acute coronary syndromes, Am J Cardiol 63 (1989), 114E-120E.
15. M. Fehr, K.S. Galliard-Grigioni and W.H. Reinhart, Influence of acute alcohol exposure on hemorheological parameters and platelet function in vivo and in vitro, Clin Hemorheol Microcirc 39 (2008), 351-358.
16. J.L. Ferreiro, J.A. Ǵomez-Hospital and D.J. Angiolillo, Platelet abnormalities in diabetes mellitus, Diab Vas Dis Res 7 (2010), 251-259.
17. K.S. Galliard-Grigioni, M. Fehr andW.H. Reinhart, Influence of combinations of acetylsalicylic acid, acetaminophen, and diclophenac on platelet aggregation, Eur J Pharmacol 595 (2008), 65-68.
18. K.S. Galliard-Grigioni andW.H. Reinhart, A randomized, controlled study on the influence of acetaminophen, diclofenac, or naproxen on aspirin-induced inhibition of platelet aggregation, Eur J Pharmacol 609 (2009), 96-99.
19. B.A. Garcia, D.M. Smalley, H. Cho, J. Shabanowitz, K. Ley and D.F. Hunt, The platelet microparticle proteome, J Proteome Res 4 (2005), 1516-1521.
20. A.Y. Gasparyan, A. Stavropoulos-Kalinoglou, D.P. Mikhailidis, K.M. Douglas and G.D. Kitas, Platelet function in rheumatoid arthritis: Arthritic and cardiovascular implications, Rheumatol Int 31 (2011), 153-164.
21. M. Gawaz, H. Langer and A.E. May, Platelets in inflammation and atherogenesis, J Clin Invest 115 (2005), 3378-3384.
22. J.C. Gilbert, T. DeFeo-Fraulini, R.M. Hutabarat, C.J. Horvath, P.G. Merlino, H.N. Marsh, J.M. Healy, S. Boufakhreddine, T.V. Holohan and R.G. Schaub, First-in-human evaluation of anti von Willebrand factor therapeutic aptamer ARC1779 in healthy volunteers, Circulation 116 (2007), 2678-2686.
23. G. Hollopeter, H.M. Jantzen, D. Vincent, G. Li, L. England, V. Ramakrishnan, R.B. Yang, P. Nurden, A. Nurden, D. Julius and P.B. Conley, Identification of the platelet ADP receptor targeted by antithrombotic drugs, Nature 409 (2001), 202-207.
24. B. Ho-Tin-Nóe, M. Demers and D.D.Wagner,Howplatelets safeguard vascular integrity, J Thromb and Hemostasis 9(Suppl 1) (2011), 56-65.
25. J.S. Huang, S.K. Ramamurthy, X. Lin and G.C. Le Breton, Cell signalling through thromboxane A2 receptors, Cell Signal 16 (2004), 521-533.
26. S.P. Jackson, Arterial thrombosis-insidious, unpredictable and deadly, Nature Medicine 17 (2011), 1423-1436.
27. S.P. Jackson and S.M. Schoenwaelder, Procoagulant platelets: Are they necrotic? Blood 116 (2010), 2011-2018.
28. A. Jordan, T. David, S. Homer-Vanniasinkam, A. Graham and P.Walker, The effects of margination and red cell augmented platelet diffusivity on platelet adhesion in complex flow, Biorheology 41 (2004), 641-653.
29. F.D. Kolodgie, H.K. Gold, A.P. Burke, D.R. Fowler, H.S. Kruth, D.K.Weber, A. Farb, L.J. Guerrero, M. Hayase, R. Kutys, J. Narula, A.V. Finn and R. Virmani, Intraplaque hemorrhage and progression of coronary atheroma, N Engl J Med 349 (2003), 2316-2325.
30. M.A. Kratzer and G.V. Born, Simulation of primary haemostasis in vitro, Haemostasis 15 (1985), 357-362.
31. T. Lehmann, H. Mairb?aurl, B. Pleisch, M. Maggiorini, P. B?artsch and W.H. Reinhart, Platelet count and function at high altitude and in high-altitude pulmonary edema, J Appl Physiol 100 (2006), 690-694.
32. G.N. Levine, P.B. Berger, D.J. Cohen, A.O. Marree, K. Rosenfield, B.S.Wiggins and S.A. Spinler, Newer pharmacotherapy in patients undergoing percutaneous coronay interventions: A guide for pharmacists and other health care professionals, Pharmacotherapy 26 (2006), 1537-1556.
33. P. Libby, Inflammation in atherosclerosis, Nature 420 (2002), 868-874.
34. Q. Long, X.Y. Xu, K.V. Ramnarine and P. Hoskins, Numerical investigation of physiologically realistic pulsatile flow through arterial stenosis, J Biomech 34 (2001), 1229-1242.
35. S.F. Mause and C. Weber, Microparticles: Protagonists of a novel communication network for intercellular information exchange, Circ Res 107 (2010), 1047-1057.
36. A.D. Michelson, Antiplatelet therapies for the treatment of cardiovascular disease, Nat Rev Drug Discov 9 (2010), 154-169.
37. P. Minuz, P. Patrignani, S. Gaino, F. Seta, M.L. Capone, S. Tacconelli, M. Degan, G. Faccini, A. Fornasiero, G. Talamini, R. Tommasoli, E. Arosio, C.L. Santonastaso, A. Lechi and C. Patrono, Determinants of platelet activation in human essential hypertension, Hypertension 43 (2004), 64-70.
38. K. Mizuno, K. Satomura, A. Miyamoto, K. Arakawa, T. Shibuya, T. Arai, A. Kurita, H. Nakamura and J.A. Ambrose, Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes, N Engl J Med 326 (1992), 287-291.
39. D.A. Morrow, E. Braunwald, M.P. Bonaca, S.F. Ameriso, A.J. Dalby, M.P. Fish, K.A. Fox, L.J. Lipka, X. Liu, J.C. Nicolau, A.J. Ophuis, E. Paolasso, B.M. Scirica, J. Spinar, P. Theroux, S.D. Wiviott, J. Strony and S.A. Murphy; TRA 2P-TIMI 50 Steering Committee and Investigators, Vorapaxar in the secondary prevention of atherothrombotic events, N Eng J Med 366 (2012), 357-362.
40. S. Nagalla, C. Shaw, X. Kong, A.A. Kondkar, L.C. Edelstein, L. Ma, J. Chen, G.S. McKnight, J.A. Ĺopez, L. Yang, Y. Jin, M.S. Bray, S.M. Leal, J.F. Dong and P.F. Bray, Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity, Blood 117 (2011), 189-197.
41. B. Nagy Jr, B. Ashby, M.P. Reilly and S.P. Kunapuli, Contribution of the P2Y12 receptor-mediated pathway to platelet hyperreactivity in hypercholesterolemia, J Thromb Haemost 9 (2011), 810-819.
42. W.S. Nesbitt, E. Westein, F.J. Tovar-Lopez, E. Toloui, A. Mitchell, J. Fu, J. Carberry, A. Fouras and S.P. Jackson, A shear gradient-dependent platelet aggregation mechanism drives thrombus formation, Nat Med 15 (2009), 665-673.
43. J.R. O'Brien, Shear-induced platelet aggregation, Lancet 335 (1990), 711-713.
44. C. Ombrello, R.C. Block and C.N. Morrell, Our expanding view of platelet functions and its clinical implications, J Cardiovasc Trans Res 3 (2010), 538-546.
45. S.M. Picker, In-vitro assessment of platelet function, Transfusion and Apheresis Science 44 (2011), 305-319.
46. W.H. Reinhart and Ch. Felix, Influence of propofol on erythrocyte morphology, blood viscosity and platelet function, Clin Hemorheol Microcirc 29 (2003), 33-40.
47. W.H. Reinhart, J. Oswald, R. Walter and M. Kuhn, Blood viscosity and platelet function in patients with obstructive sleep apnea syndrome treated with nasal continuous positive airway pressure, Clin Hemorheol Microcirc 27 (2002), 201-207.
48. W.H. Reinhart, B. Pleisch, L.G. Harris and M.L?utolf, Influence of contrast media (iopromide, ioxaglate, gadolinium-DOTA) on blood viscosity, erythrocyte morphology and platelet function, Clin Hemorheol Microcirc 32 (2005), 227-239.
49. W.H. Reinhart, L. Zehnder and T. Schulzki, Stored erythrocytes have less capacity than normal erythrocytes to support primary haemostasis, Thromb Haemost 101 (2009), 720-723.
50. Z.M. Ruggeri, Platelets in atherothrombosis, Nat Med 8 (2002), 1227-1234.
51. Z.M. Ruggeri, Platelet adhesion under flow, Microcirculation 16 (2009), 58-83.
52. B. Schicker, M. Kuhn, R. Fehr, L.M. Asmis, C. Karagiannidis andW.H. Reinhart, Particulate matter inhalation during hay storing activity induces systemic inflammation and platelet aggregation, Eur J Appl Physiol 105 (2009), 771-778.
53. G. Shi and C.N. Morrell, Platelets as initiators and mediators of inflammation at the vessel wall, Thromb Res 127 (2011), 387-390.
54. C.A. Siedlecki, B.J. Lestini, K.K. Kottke-Marchant, S.J. Eppell, D.L.Wilson and R.E. Marchant, Shear-dependent changes in the three-dimensional structure of human von Willebrand factor, Blood 88 (1996), 2939-2950.
55. M. Ueno, M. Kodali, A. Tello-Montoliu and D.J. Angiolillo, Role of platelets and antiplatelet therapy in cardiovascular disease, J Atheroscler Thromb 18 (2011), 431-432.
56. E. Varol, B. Ali Uysal and M. Ozaydin, Platelet indices in patients with pulmonary arterial hypertension, Clin Appl Thromb Hemost 17 (2011), 171-174.
57. A.S.Weyrich, S. Lindemann, N.D. Tolley, L.W. Kraiss, D.A. Dixon, T.M. Mahone, S.P. Prescott, T.M. McIntyre and G.A. Zimmerman, Change in protein phenotype without a nucleus: Translational control in platelets, Thromb Hemost 30 (2004), 491-498.
58. M.R. Yeaman, Platelets in defense against bacterial pathogens, Cell Mol Life Sci 67 (2010), 525-544.
59. O. Yousuf and D.L. Bhatt, The evolution of antiplatelet therapy in cardiovascular disease, Nat Rev Cardiol 8 (2011), 547-559.
60. R. Zhao, M.V. Kameneva and J.F. Antaki, Investigation of platelet margination phenomena at elevated shear stress, Biorheology 44 (2007), 161-177.